Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis-Reference-Cited by-同舟云学术

Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis

Published:2004-10-19 Issue:9 Volume:91 Page:1711-1717
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Chiba T,Ohtani H,Mizoi T,Naito Y,Sato E,Nagura H,Ohuchi A,Ohuchi K,Shiiba K,Kurokawa Y,Satomi S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602201.pdf

Reference24 articles.

1. Albert ML, Darnell RB (2004) Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer 4: 36–44

2. Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, Vecchiato N, Macri E, Fornasarig M, Boiocchi M (1999) High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 154: 1805–1813

3. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3: 991–998

4. Fukuzawa K, Takahashi K, Furuta K, Tagaya T, Ishikawa T, Wada K, Omoto Y, Koji T, Kakumu S (2001) Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC). J Gastroenterol 36: 681–688

5. Hamilton SR, Aaltonen LA (eds) (2000) WHO classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC press

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and immune characterization of mismatch repair deficient endocervical adenocarcinoma;The Oncologist;2024-08-07

2. Tissue adaptation of CD4 T lymphocytes in homeostasis and cancer;Frontiers in Immunology;2024-04-16

3. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment;Exploration of Targeted Anti-tumor Therapy;2024-02-28

4. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer;PeerJ;2024-01-09

5. Heterogeneity of tertiary lymphoid structures in cancer;Frontiers in Immunology;2023-12-04